Just – Evotec Biologics, a wholly owned subsidiary of Evotec SE, is an innovative and trusted US-based CDMO for complex biologics, incl. mAbs, bi/multispecifics, and biosimilars. We provide our partners with highly differentiated services for the development and manufacturing of biologics.  
Our cutting-edge end-to-end continuous biomanufacturing technology platform includes fully integrated upstream and downstream processes in cGMP facilities that enable up to 10x better productivity as compared to fed batch processes.
Our continuous manufacturing process utilizes 500 – 2000 L single-use bioreactors that consistently produce between 4-5 g/L/day enabling 15-25 day runs that match the output of 10,000 – 30,000 L stainless steel bioreactors used in traditional fed-batch systems. We can, for example, produce >30 kg of drug substance in 25 days with a 1000L bioreactor.
We have so far partnered with more than 30 organizations on more than 100 programs, spanning a wide range of modalities, including mAbs, bispecifics, Fc fusion proteins, IgG1, and IgG4.